DPP4-inhibitor-associated oral mucous membrane pemphigoid

Oral Dis. 2023 Jul;29(5):2321-2323. doi: 10.1111/odi.14234. Epub 2022 Jun 5.

Authors

Grigorios Thermos¹, Nikolaos Katsoulas², George Vilos³, Konstantinos I Tosios⁴

Affiliations

¹ Private practice, Athens, Greece.
² First Department of Pathology, Laiko General Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
³ Private practice in Oral and Maxillofacial Surgery, Athens, Greece.
⁴ Private practice and Department of Oral Pathology, Medicine & Hospital Dentistry, Dental School, National & Kapodistrian University of Athens, Athens, Greece.

PMID: 35491436
DOI: 10.1111/odi.14234

No abstract available

Keywords: DPP4; diabetes; gliptins; oral adverse event; pemphigoid.

Publication types

Letter

MeSH terms

Dipeptidyl Peptidase 4
Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
Humans
Mucous Membrane
Oral Ulcer*
Pemphigoid, Benign Mucous Membrane* / diagnosis
Pemphigoid, Benign Mucous Membrane* / drug therapy
Pemphigoid, Bullous* / chemically induced

Substances

Dipeptidyl Peptidase 4
Dipeptidyl-Peptidase IV Inhibitors